The US president has launched the website to reduce the cost of prescription drugs for Americans.

US President Donald Trump announced earlier this week that his administration would launch a new website, called TrumpRx, which will allow American consumers to buy prescription drugs from pharmaceutical companies at discounted prices.

Pfizer, the first United States pharmaceutical group to sign up to the website, said it would offer discounts of up to 85 percent on the cost of its medicines for those not using health insurance policies to pay and for those on the government’s low-cost insurance programme, Medicaid. Pfizer will also sell medicines to the Medicaid programme itself at lower prices.

The announcement prompted shares in the pharmaceuticals sector to lift sharply this week, signalling a favourable response from markets and the pharmaceuticals industry.

Here’s what we know about the new service, why it is being launched and how it will work.

What is TrumpRx and when is it being launched?

The new website will be launched in early 2026. It is a platform from which consumers will be able to buy prescription medicines directly from pharmaceutical companies without going through insurance.

On the site, consumers will be able to search for the prescription drug required and then be directed to the drug’s manufacturing company.

They will have access to discounted prices much closer to those typically paid by national health services in foreign countries at what are known as “most favoured nation” prices.

Beneficiaries of Medicaid – the federal government insurance programme for adults and children from lower-income backgrounds – will also be able to use the site.

Advertisement

“By taking this bold step, we’re ending the era of global price gouging at the expense of